← Open Payments lookup

MARIANNE JOHNSON: Open Payments

NPI 1053981365 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,575 in 91 payments from 17 companies in 2025. Trend: 2023 $1,445 · 2024 $1,772 · 2025 $1,575

Food & beverage: $1,575
CompanyPaymentsAmount
ABBVIE INC.26$492
Salix Pharmaceuticals, a division of Bausch Health US, LLC27$274
Celltrion USA Inc.6$120
Ardelyx, Inc.5$109
Aimmune Therapeutics, Inc.6$102
Janssen Biotech, Inc.3$69
QOL Medical, LLC2$64
Ipsen Biopharmaceuticals, Inc3$63
GENZYME CORPORATION2$58
Takeda Pharmaceuticals U.S.A., Inc.2$49

Products named: XIFAXAN, LINZESS, RINVOQ, VEGZELMA, IBSRELA, ZENPEP, MAVYRET, TREMFYA.

Industry payments across TX — which companies pay providers there.